The role of MMP genes in recurrent depressive disorders and cognitive functions

Validation of biomarkers in subcortical ischaemic vascular disease of the Binswanger type: approach to targeted treatment trials

(2015) G. A. Rosenberg et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Functional polymorphism of matrix metalloproteinase-9 (MMP9) gene is not associated with schizophrenia and with its deficit subtype

(2015) Przemyslaw Bienkowski et al.   Pharmacological Reports

Mechanisms Underlying Neurocognitive Dysfunctions in Recurrent Major Depression

(2015) Michael Maes   MEDICAL SCIENCE MONITOR

Inhibition of matrix metalloproteinases-2 and -9 prevents cognitive impairment induced by pneumococcal meningitis in Wistar rats

(2014) Tatiana Barichello et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

MMPs: a novel drug target for schizophrenia

(2014) Kanwaljit Chopra et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Role for MMP-9 in stress-induced downregulation of nectin-3 in hippocampal CA1 and associated behavioural alterations

(2014) Michael A. van der Kooij et al.   Nature Communications

Maintenance of long-term potentiation in hippocampal mossy fiber-CA3 pathway requires fine-tuned MMP-9 proteolytic activity

(2013) Grzegorz Wiera et al.   HIPPOCAMPUS

Matrix metalloproteinase levels in early HIV infection and relation to in vivo brain status

(2013) Suyang Li et al.   JOURNAL OF NEUROVIROLOGY

Serum Levels of Matrix Metalloproteinases: Implications in Clinical Neurology

(2012) Fredrik Romi et al.   EUROPEAN NEUROLOGY

Total Antioxidant Status Correlates with Cognitive Impairment in Patients with Recurrent Depressive Disorder

(2012) Monika Talarowska et al.   NEUROCHEMICAL RESEARCH

Nuclear localization of Matrix metalloproteinases

(2012) Ferdinando Mannello et al.   PROGRESS IN HISTOCHEMISTRY AND CYTOCHEMISTRY

The Potential Role of Metalloproteinases in Neurogenesis in the Gerbil Hippocampus Following Global Forebrain Ischemia

(2011) Luiza Wójcik-Stanaszek et al.   PLoS One

Matrix Metalloproteinases Are Associated With Increased Blood–Brain Barrier Opening in Vascular Cognitive Impairment

(2011) Eduardo Candelario-Jalil et al.   STROKE

Expression of matrix metalloproteinases 2 and 9 in human gastric cancer and superficial gastritis

(2010) Clara Luz Sampieri   WORLD JOURNAL OF GASTROENTEROLOGY

Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease

(2010) Erik Stomrud et al.   Alzheimers Research & Therapy

Neuroinflammation and MMPs: potential therapeutic targets in neonatal hypoxic-ischemic injury

(2009) Christopher C Leonardo et al.   Journal of Neuroinflammation

Matrix Metalloprotease-9 Inhibition Improves Amyloid  -Mediated Cognitive Impairment and Neurotoxicity in Mice

(2009) H. Mizoguchi et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Biobehavioral Influences on Matrix Metalloproteinase Expression in Ovarian Carcinoma

(2008) S. K. Lutgendorf et al.   CLINICAL CANCER RESEARCH

Metalloproteinase’s Activity and Oxidative Stress in Mild Cognitive Impairment and Alzheimer’s Disease

(2008) Sagrario Martín-Aragón et al.   NEUROCHEMICAL RESEARCH

MMPs in the central nervous system: Where the good guys go bad

(2007) S AGRAWAL et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY